Frazier Financial Advisors, LLC Bio N Tech Se Transaction History
Frazier Financial Advisors, LLC
- $129 Billion
- Q3 2024
A detailed history of Frazier Financial Advisors, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 262 shares of BNTX stock, worth $28,264. This represents 0.02% of its overall portfolio holdings.
Number of Shares
262
Previous 265
1.13%
Holding current value
$28,264
Previous $21.3 Million
46.12%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding BNTX
# of Institutions
323Shares Held
38.9MCall Options Held
845KPut Options Held
1.28M-
Baillie Gifford & CO8.31MShares$896 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$517 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$472 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$316 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$204 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.2B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...